Patients' satisfaction following laparoscopic cornuectomy for removal of hysteroscopic sterilization devices.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 05 06 2020
revised: 25 09 2020
accepted: 07 10 2020
pubmed: 14 10 2020
medline: 25 2 2023
entrez: 13 10 2020
Statut: ppublish

Résumé

To evaluate patients' satisfaction and evolution of pre-operative symptoms at 6 months following laparoscopic cornuectomy for hysteroscopic sterilization implants removal. Retrospective study including all patients undergoing laparoscopic cornuectomy for implants removal in a tertiary care setting from January 2017 to October 2018. All women suffered from persistent and treatment-resistant gynecologic and non-gynecologic complaints since sterilization procedure. Patents' satisfaction was evaluated with the PGI-I questionnaire at 2 and 6 months following surgery. Overall, 104 patients were enrolled. Main symptoms comprised asthenia (n = 80), chronic pelvic pain (n = 80), arthralgia (n = 70), abnormal uterine bleeding (n = 42) and headache (n = 40). Cornuectomy was feasible in all cases and led to complete devices removal in 101 women. Mean length of stay was 1.8 days, while outpatient management was feasible in 45.2 % of cases. One grade 3 complication occurred along the study period (hemoperitoneum requiring reoperation). Surgery was associated with a significant decrease in symptom occurrence, except for alopecia and weight loss. Patients' satisfaction was high: 91 % at 2 months and 97.6 % at 6 months reported an improvement in their health status compared to baseline situation. Satisfaction regarding each symptom was consistent with overall assessment, with most patients reporting significant improvement at both 2 and 6 months. Laparoscopic cornuectomy is feasible and associated with high mid-term satisfaction in patients suffering from adverse effects attributed to hysteroscopic sterilization implants.

Identifiants

pubmed: 33049363
pii: S2468-7847(20)30303-2
doi: 10.1016/j.jogoh.2020.101939
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101939

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Camille Eychenne (C)

CHU Toulouse, Pôle Femme Mère Couple, Hôpital Paule de Viguier, 31059, Toulouse, France.

Fabien Vidal (F)

CHU Toulouse, Pôle Femme Mère Couple, Hôpital Paule de Viguier, 31059, Toulouse, France; University Paul Sabatier Toulouse III, 31330, Toulouse, France. Electronic address: vidal.fabien@chu-toulouse.fr.

Arianne Weyl (A)

University Paul Sabatier Toulouse III, 31330, Toulouse, France; CHU Toulouse, Pôle Femme Mère Couple, Hôpital Rangueil, 31059, Toulouse, France.

Paul Guerby (P)

CHU Toulouse, Pôle Femme Mère Couple, Hôpital Paule de Viguier, 31059, Toulouse, France; University Paul Sabatier Toulouse III, 31330, Toulouse, France.

Charlotte Vaysse (C)

University Paul Sabatier Toulouse III, 31330, Toulouse, France; CHU Toulouse, Pôle Femme Mère Couple, Hôpital Rangueil, 31059, Toulouse, France.

Yann Tanguy Le Gac (Y)

CHU Toulouse, Pôle Femme Mère Couple, Hôpital Paule de Viguier, 31059, Toulouse, France.

Olivier Parant (O)

CHU Toulouse, Pôle Femme Mère Couple, Hôpital Paule de Viguier, 31059, Toulouse, France; University Paul Sabatier Toulouse III, 31330, Toulouse, France.

Tiphaine Siebert (T)

University Paul Sabatier Toulouse III, 31330, Toulouse, France; CHU Toulouse, Pôle Femme Mère Couple, Hôpital Rangueil, 31059, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH